Aarey Drugs & Pharmaceuticals Limited (BOM:524412)
India flag India · Delayed Price · Currency is INR
70.40
+2.96 (4.39%)
At close: Feb 12, 2026

BOM:524412 Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Operating Revenue
3,9094,7393,9564,1904,9283,484
Other Revenue
--69.65-1.7330.12
3,9094,7394,0264,1904,9293,514
Revenue Growth (YoY)
-32.97%17.73%-3.91%-15.01%40.27%16.79%
Cost of Revenue
3,8434,6213,8194,0394,7213,378
Gross Profit
65.46118.23206.4150.87208.51136.38
Selling, General & Admin
8.4616.7414.2115.5420.463.96
Other Operating Expenses
29.1430.977.552.6767.940.91
Operating Expenses
61.7467.09108.6983.95108.2454.07
Operating Income
3.7351.1597.7166.92100.2782.31
Interest Expense
-33.95-35.42-41.95-25.4-18.13-23.18
Interest & Investment Income
56.0456.04-26.3320.0924.29
Currency Exchange Gain (Loss)
0.480.48-0.52-4.490.390.04
Other Non Operating Income (Expenses)
31.3-11.23-1.8-3.26-2.24-0.44
Pretax Income
57.5961.0253.4360.1100.3783.01
Income Tax Expense
23.2420.786.5922.3934.8217.87
Net Income
34.3540.2446.8437.7165.5565.14
Net Income to Common
34.3540.2446.8437.7165.5565.14
Net Income Growth
-39.80%-14.09%24.20%-42.47%0.62%12.44%
Shares Outstanding (Basic)
292825252423
Shares Outstanding (Diluted)
292825252423
Shares Change (YoY)
4.15%11.18%-0.26%5.84%2.95%-
EPS (Basic)
1.201.421.841.482.722.79
EPS (Diluted)
1.191.421.841.482.722.79
EPS Growth
-42.64%-22.83%24.32%-45.59%-2.36%12.44%
Free Cash Flow
-50.96-37.16-23.25-17.0325.98
Free Cash Flow Per Share
-1.80-1.46-0.91-0.711.11
Gross Margin
1.68%2.50%5.13%3.60%4.23%3.88%
Operating Margin
0.10%1.08%2.43%1.60%2.03%2.34%
Profit Margin
0.88%0.85%1.16%0.90%1.33%1.85%
Free Cash Flow Margin
-1.07%-0.92%-0.56%-0.34%0.74%
EBITDA
25.0370.6114.6982.66120.1591.51
EBITDA Margin
0.64%1.49%2.85%1.97%2.44%2.60%
D&A For EBITDA
21.319.4516.9815.7419.889.2
EBIT
3.7351.1597.7166.92100.2782.31
EBIT Margin
0.10%1.08%2.43%1.60%2.03%2.34%
Effective Tax Rate
40.36%34.05%12.34%37.25%34.69%21.53%
Revenue as Reported
4,0504,8384,0264,2174,9543,554
Advertising Expenses
-3.361.712.563.891.59
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.